Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC
- 27 December 2017
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 25 (3) , 702-708
Abstract
Mucinous appendiceal tumors (MAT) are rare neoplasms that can metastasize to the peritoneum and often are treated with cytoreductive surgery (CRS) and HIPEKeywords
Funding Information
- UCSD Clinical and Translational Research Institute grant (UL1TR001442)
This publication has 22 references indexed in Scilit:
- Significance of Serum Tumor Marker Levels in Peritoneal Carcinomatosis of Appendiceal OriginAnnals of Surgical Oncology, 2012
- Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyJournal of Clinical Oncology, 2012
- Aggressive Management of Peritoneal Carcinomatosis from Mucinous Appendiceal NeoplasmsAnnals of Surgical Oncology, 2012
- Appendiceal Mucinous NeoplasmsAmerican Journal of Surgical Pathology, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- The intraoperative staging systems in the management of peritoneal surface malignancyJournal of Surgical Oncology, 2008
- Appendiceal Mucinous Tumors and Pseudomyxoma PeritoneiAdvances in Anatomic Pathology, 2005
- Appendiceal tumorsDiseases of the Colon & Rectum, 1998
- Pseudomyxoma Peritonei Long-Term Patient Survival with an Aggressive Regional ApproachAnnals of Surgery, 1994